For instance, the presence of small regions of enhancement, a larger non-enhancing tumor component, well-defined tumor margins, and T1-weighted hypointense areas with suppressed FLAIR signals within necrotic regions are indicative of an IDH1 mutation [23,24]. The gene discussed is IDH1; the disease is neoplasm.